Replimune Group, Inc. — Director's Dealing 2018

Jul 20, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2018-07-19

Reporting Person: Dhingra Kapil (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.75	2026-01-21	Common Stock (43169)		Direct
Stock Option (Right to Buy)	$1.75	2027-01-21	Common Stock (43169)		Direct
Stock Option (Right to Buy)	$3.83	2028-01-21	Common Stock (68872)		Direct

Footnotes

F1: All of the shares underlying this stock option vested on January 21, 2016.

F2: All of the shares underlying this stock option vested on January 21, 2017.

F3: All of the shares underlying this stock option vested on January 21,2018.